Wednesday 2 January 2019

Chlorine Market Expected To Trigger A Revenue Increase To USD 39.31 Billion By 2024:Key Participant Hanwha Chemical Corporation, Ineos Group Ltd.


San Francisco, 02 January 2019, Chlorine Market Analysis By Application (EDC/PVC, Organic Chemicals, Inorganic Chemicals, Isocyanates, Chlorinated Intermediates, Propylene Oxide, Pulp & Paper, C1/C2 Aromatics, Water Treatment) And Segment Forecast To 2024

The global chlorine market is expected to reach USD 39.31 billion by 2024, according to a new report by Grand View Research, Inc. Chlorine serves as an important raw material in various chemical industries. It is also an essential ingredient for PVC production, which has observed increasing demand in construction, automotive, and packaging industries. These factors are anticipated to drive the global chlorine market. 
Increasing demand for chlorine across various industries for manufacturing intermediate products such as hydrochloric acid, chlorides, etc. is expected to be a key factor influencing the market growth. 
Price fluctuations due to uneven demand and supply particularly in Asia Pacific are expected to pose challenges to key industry participants in the region. Chlorine is highly reactive when it comes in contact with other materials which increase handling risk. Toxicological nature of chlorine also adds up to the market challenges. 
EDC/PVC was the largest application segment and accounted for 34.5% of global demand in 2015. Escalating PVC demand in construction industry is expected to drive this segment over the forecast period. It is also expected to witness the highest growth of 4.8% over the forecast period. 
Access Full Research Report On Chlorine Market Analysis:

Further key findings from the report suggest:
·         Global chlorine market demand was 71.26 million tons in 2015 and is expected to reach 104.70 million tons by 2024, growing at a CAGR of 43% from 2016 to 2024
·         Asia Pacific was the leading regional market and accounted for 56.6% of total market volume in 2015. Increasing construction spending in China, India, Indonesia and Thailand is expected to drive the regional market over the forecast period. The region is also expected to witness the fastest growth of 4.7% over the forecast period due to incessant demand for chlorine in construction as well as chemical industry.
·         North America is expected to witness moderate growth mainly on account of recovery of construction in industry in the U.S. The region is expected to grow at an estimated CAGR of 4.2% from 2016 to 2024.
·         Key market players include Hanwha Chemical Corporation, Ineos Group Ltd., The Dow Chemical Company, Tosoh Corporation, PPG Industries, Tata Chemicals Ltd., BASF SE, FMC Corporation, Olin Corporation, Formosa Plastics Corporation, Occidental Petroleum Corporation, Xinjiang Zhongtai Chemicals Co. Ltd., and Nirma Ltd. 
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/disinfectants-and-preservatives
Grand View Research has segmented the global chlorine market on the basis of application and region:
Global Chlorine Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2024)
·         EDC/PVC
·         Organic Chemicals
·         Inorganic Chemicals
·         Isocyanates
·         Chlorinated Intermediates
·         Propylene Oxide
·         Pulp & Paper
·         C1/C2, Aromatics
·         Water Treatment
·         Others
Global Chlorine Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2024)
·         North America
o    U.S.
·         Europe
o    Germany
o    France
o    UK
·         Asia Pacific
o    China
o    India
o    Japan
o    South Korea
·         Middle East & Africa
·         Central & South America

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



Tuesday 1 January 2019

Infectious Disease Therapeutics Market Likely To Reach A Valuation Of Around USD 86.2 Billion By 2025:Key Participant Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd.


San Francisco, 31 December 2018,  Infectious Disease Therapeutics Market Analysis By Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis, and HPV infection), By Region, And Segment Forecasts, 2018 – 2025.
The global top6 infectious disease therapeutics market is expected to reach USD 86.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.
Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.
In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.
North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.
Access Full Research Report On Infectious Disease Therapeutics Market Analysis:www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market

Further Key Findings From the Report Suggest:
·         The HIV therapeutics segment held the largest revenue share in 2016 due to high number of HIV cases globally
·         North America dominated the global market owing to the strong reimbursement framework coupled with high adoption rate of treatments for infectious diseases
·         The HPV therapeutics segment is estimated to grow at the highest rate during the forecast period
·         Some of the key players areNovartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the top 6 infectious disease therapeutics market on the basis of disease type and region:
Disease Type Outlook (Revenue, USD Million, 2014 - 2025)
·         HIV
o    Emtriva
o    Aptivus
o    Isentress
o    Lexiva/Telzir
o    Selzentry
o    Tivicay 
o    Atripla
o    Complera
o    Genvoya
o    Odefsey
o    Stribild
o    Truvada
o    Triumeq
o    Descovy
o    Vitekta
o    Others
·         Influenza
o    Relenza
o    Tamiflu 
o    Rapivab 
o    Others
·         TB
o    Sirturo
o    Others
·         Malaria
o    Coartem
o    Others
·         HPV
·         Hepatitis
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



Aseptic Packaging Market Expected To Trigger A Revenue Increase To USD 85.47 Billion By 2024:Key Participant Robert Bosch GmbH, Tetra Pak International S.A.,


San Francisco, 02 January 2019,  Aseptic Packaging Market Analysis By Product (Cartons, Bottles, Bags & Pouches, Prefilled Syringes, Vials & Ampoules), By Application (Food, Beverage, Pharmaceuticals) And Segment Forecasts To 2024 .
The global aseptic packaging market is expected to reach USD 85.47 billion by 2024, according to a new report by Grand View Research, Inc. Aseptic packaging allows the end –users to meet the consumer demand for sterile and safe food and pharmaceutical products. The technology offers extended shelf stability at ambient temperature, which eliminates the need for refrigeration. As a result, aseptic packaging is expected to witness high demand from the foodservice entities and retailers.
The aseptic packaging manufacturers supply their product either in the form of rolls or blanks. The roll-fed filling technique dominates the market and has been adopted by the major manufacturers such as Tetra Pack. Whereas, companies such as Elopak and SIG have adopted the blank filled systems. These two technologies are not interchangeable since the process and equipment associated with these two methods are different. As a result, buyers are unable to switch from one process to other. High capital investment is likely to be a key restraining factor for the industry.
Investment, Divestment, capacity expansion and new product development are the key strategies adopted by the major players in order to strengthen their position in the market. The industry players are likely to invest more on R&D and innovation owing to continuously changing demand from end-users in terms of product quality, performance, and appearance. The major manufacturers are likely to adopt acquisition strategies in order to meet the rising consumer demand and cope with the new technologies.
Access Full Research Report On Functional Textile Finishing Agents Market  Analysis:
www.grandviewresearch.com/industry-analysis/aseptic-packaging-market

Further key findings from the report suggest:
·         The food was the key application segment for the industry and is expected to grow at a CAGR of over 11% over the next eight years. The process is carried out at lower temperatures. Thus the texture, appearance, flavor and nutritional value of the products remains unaffected. In addition, light weight and recyclability offered by aseptic packaging are expected to have a positive impact on the industry growth over the forecast period.
·         Prefilled syringes demand in the industry was valued over 4.5 billion in 2015 and is expected to grow at a CAGR of over 11% from 2016 to 2024. Advances in biotechnology and rising demand for biologics is anticipated to drive demand over the eight years. The technology offers safety against drug degradation and contaminants. Furthermore, it eliminates the need for refrigeration and thus lowering the cost associated with the maintenance of the product.
·         Asia Pacific is expected to be the fastest growing market owing to rapid growth of food and beverage packaging sector in the region. China was the largest market for aseptic packaging in Asia Pacific and accounted for over 50% of the regional demand in 2015. Increasing consumer disposable income and changing dietary habits in countries such as India, China, Japan, and Korea are expected to raise demand for packaged ready-to-eat meals, frozen meat, and juices, which is anticipated to have a positive impact on the industry growth over the projected period.
·         The key players in the industry are The key players in the market include Robert Bosch GmbH, Tetra Pak International S.A., Greatview Aseptic Packaging Co., Ltd., Schott AG, SIG Combiboc Obeikan, Reynolds Group Holdings Limited, and Agropur Inc.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers
Grand View Research has segmented the aseptic packaging market on the basis of product, application and region:
Aseptic Packaging Market Product Outlook (Revenue, USD Million, 2013 - 2024)
·         Cartons
·         Bottles
·         Bags & pouches
·         Prefilled syringes
·         Vials & ampoules
·         Others
Aseptic Packaging Market Application Outlook (Revenue, USD Million, 2013 - 2024)
·         Food
·         Beverages
·         Pharmaceuticals
·         Others
Aseptic Packaging Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Brazil
·         Middle East & Africa
o    South Africa

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/